{
  "trial_id": "NCT00530179",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histological diagnosis of Diffuse Large B-cell Lymphoma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age 18-65 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No central nervous system involvement by lymphoma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "No more than 1 prior cycle of R-CHOP chemotherapy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "At least 1 adverse International Prognostic Index factor at diagnosis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adequate organ function: Cardiac: LVEF >45%",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age 18-65 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Diagnosis of Diffuse Large B-Cell Lymphoma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adverse Prognosis = Stage 3 or 4 and elevated LDH",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No more than one prior cycle of R-CHOP chemotherapy",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate cardiac function",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "No central nervous system involvement by lymphoma",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Histological diagnosis other than Diffuse Large B-cell Lymphoma",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Pregnant or lactating females",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Concurrent use of other anti-cancer therapies",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Other serious co-morbid illness that would compromise study participation.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Prior malignancy unless non-melanoma skin cancer, carcinoma in-situ of the cervix (CIN) or breast, or malignancy treated more than 5 years previously with no evidence of recurrent disease since initial treatment.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "More than 1 prior cycle of Rituximab, cyclophosphamide, or doxorubicin.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Prior HDCT/ASCT or prior radiotherapy.",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has a history of CVA, neurogenic bladder with indwelling suprapubic catheter and multiple prior admissions for UTIs. They have a non-obstructing stone in the L ureter and are currently on ditropan.",
  "_meta": {
    "topic_id": "13",
    "trial_id": "NCT00530179",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}